Nummular Eczema: An Updated Review

Author(s): Alexander K.C. Leung*, Joseph M. Lam, Kin Fon Leong, Amy A.M. Leung, Alex H.C. Wong, Kam L. Hon

Journal Name: Recent Patents on Inflammation & Allergy Drug Discovery
Continued as Recent Advances in Inflammation & Allergy Drug Discovery

Volume 14 , Issue 2 , 2020


Abstract:

Background: Nummular eczema may mimic diseases that present with annular configuration and the differential diagnosis is broad.

Objective: This article aimed to provide an update on the evaluation, diagnosis, and treatment of nummular eczema.

Methods: A PubMed search was performed in using the key terms “nummular eczema”, “discoid eczema”, OR “nummular dermatitis”. The search strategy included meta-analyses, randomized controlled trials, clinical trials, observational studies, and reviews. The search was restricted to English literature. The information retrieved from the above search was used in the compilation of the present article. Patents were searched using the key terms “nummular eczema”, “discoid eczema”, OR “nummular dermatitis” in www.google.com/patents and www.freepatentsonline.com.

Results: Nummular eczema is characterized by sharply defined, oval or coin-shaped, erythematous, eczematous plaques. Typically, the size of the lesion varies from 1 to 10cm in diameter. The lesions are usually multiple and symmetrically distributed. Sites of predilection include the lower limbs followed by the upper limbs. The lesions are usually intensely pruritic. The diagnosis is mainly clinical based on the characteristic round to oval erythematous plaques in a patient with diffusely dry skin. Nummular eczema should be distinguished from other annular lesions. Dermoscopy can reveal additional features that can be valuable for correct diagnosis. Biopsy or laboratory tests are generally not necessary. However, a potassium hydroxide wet-mount examination of skin scrapings should be performed if tinea corporis is suspected. Because contact allergy is common with nummular eczema, patch testing should be considered in patients with chronic, recalcitrant nummular eczema. Avoidance of precipitating factors, optimal skin care, and high or ultra-high potency topical corticosteroids are the mainstay of therapy. Recent patents related to the management of nummular eczema are also discussed.

Conclusion: With proper treatment, nummular eczema can be cleared over a few weeks, although the course can be chronic and characterized by relapses and remissions. Moisturizing of the skin and avoidance of identifiable exacerbating factors, such as hot water baths and harsh soaps may reduce the frequency of recurrence. Diseases that present with annular lesions may mimic nummular eczema and the differential diagnosis is broad. As such, physicians must be familiar with this condition so that an accurate diagnosis can be made, and appropriate treatment initiated.

Keywords: Coin-shaped plaques, discoid eczema, high potency corticosteroids, moisturizers, nummular dermatitis, nummular eczema.

[1]
Jiamton S, Tangjaturonrusamee C, Kulthanan K. Clinical features and aggravating factors in nummular eczema in Thais. Asian Pac J Allergy Immunol 2013; 31(1): 36-42.
[PMID: 23517392]
[2]
Krupa Shankar DS, Shrestha S. Relevance of patch testing in patients with nummular dermatitis. Indian J Dermatol Venereol Leprol 2005; 71(6): 406-8.
[http://dx.doi.org/10.4103/0378-6323.18945] [PMID: 16394482]
[3]
Leung AKC, Barankin B. What is causing these oozing, crusting plaques on a man’s shins? Consultant 2017; 57: 29-31.
[4]
Zirwas MJ. Nummular eczema. In: Post TW, ed. UpTo Date. Waltham, MA. (Accessed on June 4, 2020).
[5]
Devergie M. Traite Pratique des Maladies de la Peau. (2nd ed.). Paris: Masson et Cie. 1857; pp. 238.
[6]
Leung AK, Robson WL. Nummular eczema. The Encyclopedia of Molecular Mechanisms of Disease Berlin Springer-Verlag. 2009; pp. 1502-3.
[7]
Poudel RR, Belbase B, Kafle NK. Nummular eczema. J Community Hosp Intern Med Perspect 2015; 5(3): 27909.
[http://dx.doi.org/10.3402/jchimp.v5.27909] [PMID: 26091664]
[8]
Lee CS, Lim HW. Cutaneous diseases in Asians. Dermatol Clin 2003; 21(4): 669-77.
[http://dx.doi.org/10.1016/S0733-8635(03)00078-0] [PMID: 14717407]
[9]
Järvikallio A, Harvima IT, Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch Dermatol Res 2003; 295(1): 2-7.
[http://dx.doi.org/10.1007/s00403-002-0378-z] [PMID: 12709813]
[10]
Maddison B, Parsons A, Sangueza O, Sheehan DJ, Yosipovitch G. Retrospective study of intraepidermal nerve fiber distribution in biopsies of patients with nummular eczema. Am J Dermatopathol 2011; 33(6): 621-3.
[http://dx.doi.org/10.1097/DAD.0b013e3181fe4c3c] [PMID: 21712693]
[11]
Lange L, Rietschel E, Hunzelmann N, Hartmann K. Elevated levels of tryptase in children with nummular eczema. Allergy 2008; 63(7): 947-9.
[http://dx.doi.org/10.1111/j.1398-9995.2008.01731.x] [PMID: 18588568]
[12]
Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep 2008; 8(4): 306-11.
[http://dx.doi.org/10.1007/s11882-008-0049-z] [PMID: 18606082]
[13]
Kim WJ, Ko HC, Kim MB, Kim DW, Kim JM, Kim BS. Features of Staphylococcus aureus colonization in patients with nummular eczema. Br J Dermatol 2013; 168(3): 658-60.
[http://dx.doi.org/10.1111/j.1365-2133.2012.11072.x] [PMID: 22630164]
[14]
Tanaka T, Satoh T, Yokozeki H. Dental infection associated with nummular eczema as an overlooked focal infection. J Dermatol 2009; 36(8): 462-5.
[http://dx.doi.org/10.1111/j.1346-8138.2009.00677.x] [PMID: 19691752]
[15]
Sakurane M, Shiotani A, Furukawa F. Therapeutic effects of antibacterial treatment for intractable skin diseases in Helicobacter pylori-positive Japanese patients. J Dermatol 2002; 29(1): 23-7.
[http://dx.doi.org/10.1111/j.1346-8138.2002.tb00160.x] [PMID: 11837570]
[16]
Pietrzak A, Chodorowska G, Urban J, Bogucka V, Dybiec E. Cutaneous manifestation of giardiasis - case report. Ann Agric Environ Med 2005; 12(2): 299-303.
[PMID: 16457489]
[17]
Satoh T, Takayama K, Sawada Y, Yokozeki H, Nishioka K. Chronic nodular prurigo associated with nummular eczema: Possible involvement of odontogenic infection. Acta Derm Venereol 2003; 83(5): 376-7.
[http://dx.doi.org/10.1080/00015550310003728] [PMID: 14609109]
[18]
Aoyama H, Tanaka M, Hara M, Tabata N, Tagami H. Nummular eczema: An addition of senile xerosis and unique cutaneous reactivities to environmental aeroallergens. Dermatology (Basel) 1999; 199(2): 135-9.
[http://dx.doi.org/10.1159/000018220] [PMID: 10559579]
[19]
Halberg M. Nummular eczema. J Emerg Med 2012; 43(5): e327-8.
[http://dx.doi.org/10.1016/j.jemermed.2011.05.031] [PMID: 21719233]
[20]
Le Coz CJ. Contact nummular (discoid) eczema from depilating cream. Contact Dermat 2002; 46(2): 111-2.
[http://dx.doi.org/10.1034/j.1600-0536.2002.460212.x] [PMID: 11918608]
[21]
Adachi A, Horikawa T, Takashima T, Ichihashi M. Mercury-induced nummular dermatitis. J Am Acad Dermatol 2000; 43(2 Pt 2): 383-5.
[http://dx.doi.org/10.1067/mjd.2000.102457] [PMID: 10901730]
[22]
Bonamonte D, Foti C, Vestita M, Ranieri LD, Angelini G. Nummular eczema and contact allergy: A retrospective study. Dermatitis 2012; 23(4): 153-7.
[http://dx.doi.org/10.1097/DER.0b013e318260d5a0] [PMID: 22828253]
[23]
Caraffini S, Lisi P. Nummular dermatitis-like eruption from ethylenediamine hydrochloride in 2 children. Contact Dermat 1987; 17(5): 313-4.
[http://dx.doi.org/10.1111/j.1600-0536.1987.tb01486.x] [PMID: 2963728]
[24]
Morrow DM, Rapaport MJ, Strick RA. Hypersensitivity to aloe. Arch Dermatol 1980; 116(9): 1064-5.
[http://dx.doi.org/10.1001/archderm.1980.01640330102026] [PMID: 7416761]
[25]
Pigatto PD, Guzzi G, Persichini P. Nummular lichenoid dermatitis from mercury dental amalgam. Contact Dermat 2002; 46(6): 355-6.
[http://dx.doi.org/10.1034/j.1600-0536.2002.460608.x] [PMID: 12190626]
[26]
Lugović-Mihić L, Bukvić I, Bulat V, Japundžić I. Factors contributing to chronic urticaria/angioedema and nummular eczema resolution – which findings are crurcial? Acta Clin Croat 2019; 58(4): 595-603.
[PMID: 32595243]
[27]
Schena D, Papagrigoraki A, Girolomoni G. Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema. Dermatol Ther 2008; 21(Suppl. 2): S35-8.
[http://dx.doi.org/10.1111/j.1529-8019.2008.00231.x] [PMID: 18837732]
[28]
Flendrie M, Vissers WH, Creemers MC, de Jong EM, van de Kerkhof PC, van Riel PL. Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study. Arthritis Res Ther 2005; 7(3): R666-76.
[http://dx.doi.org/10.1186/ar1724] [PMID: 15899052]
[29]
Shen Y, Pielop J, Hsu S. Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection. Arch Dermatol 2005; 141(1): 102-3.
[http://dx.doi.org/10.1001/archderm.141.1.102-b] [PMID: 15655158]
[30]
Truong A, Le S, Kiuru M, Maverakis E. Nummular dermatitis on guselkumab for palmoplantar psoriasis. Dermatol Ther (Heidelb) 2019; 32(4): e12954.
[http://dx.doi.org/10.1111/dth.12954] [PMID: 31070862.]
[31]
Iwahira Y, Nagasao T, Shimizu Y, Kuwata K, Tanaka Y. Nummular eczema of breast: A potential dermatologic complication after mastectomy and subsequent breast reconstruction. Plast Surg Int 2015; 2015: 209458.
[http://dx.doi.org/10.1155/2015/209458] [PMID: 26380109.]
[32]
Rzepecki AK, Wang J, Urman A, Amin B, McLellan B. Nummular eczema of the breast following surgery and reconstruction in breast cancer patients. Acta Oncol 2018; 57(11): 1586-8.
[http://dx.doi.org/10.1080/0284186X.2018.1489145] [PMID: 30014750]
[33]
Yamamoto T. Nummular eczema and isomorphic Koebner response. Clin Exp Dermatol 2020; 45(5): 616-8.
[http://dx.doi.org/10.1111/ced.14195] [PMID: 32064654]
[34]
Moore MM, Elpern DJ, Carter DJ. Severe, generalized nummular eczema secondary to interferon alfa-2b plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection. Arch Dermatol 2004; 140(2): 215-7.
[http://dx.doi.org/10.1001/archderm.140.2.215] [PMID: 14967798]
[35]
Suh KS, Park JB, Yang MH, Choi SY, Hwangbo H, Jang MS. Diagnostic usefulness of dermoscopy in differentiating lichen aureus from nummular eczema. J Dermatol 2017; 44(5): 533-7.
[http://dx.doi.org/10.1111/1346-8138.13701] [PMID: 27914108]
[36]
Bilgic SA, Cicek D, Demir B. Dermoscopy in differential diagnosis of inflammatory dermatoses and mycosis fungoides. Int J Dermatol 2020; 59(7): 843-50.
[37]
Hon KL, Luk DC, Leong KF, Leung AK. Cupping therapy may be harmful for eczema: A Pubmed search. Case Rep Pediatr 2013; 2013: 605829.
[http://dx.doi.org/10.1155/2013/605829] [PMID: 24282650]
[38]
Hon KL, Loo S, Leung AKC, Li JTS, Lee VWY. An overview of drug discovery efforts for eczema: Why is this itch so difficult to scratch? Expert Opin Drug Discov 2020; 15(4): 487-98.
[http://dx.doi.org/10.1080/17460441.2020.1722639] [PMID: 32050818]
[39]
Kelly BP. Superficial fungal infections. Pediatr Rev 2012; 33(4): e22-37.
[http://dx.doi.org/10.1542/pir.33-4-e22] [PMID: 22474120]
[40]
Khosravi AR, Mansouri P, Nikaein D, et al. Severe tinea corporis due to Trichophyton verrucosum mimicking discoid lupus erythematosus. J Mycol Med 2012; 22(1): 92-5.
[http://dx.doi.org/10.1016/j.mycmed.2011.12.001] [PMID: 23177820]
[41]
Leung AK, Hon KL, Robson WL. Atopic dermatitis. Adv Pediatr 2007; 54: 241-73.
[http://dx.doi.org/10.1016/j.yapd.2007.03.013] [PMID: 17918474]
[42]
Leung AK, Barankin B. An annular lesion in the elbow. Am Fam Physician 2016; 93(5): 397-8.
[PMID: 26926977]
[43]
Leung AKC, Lam JM. Erythema dyschromicum perstans in an 8-year-old Indian child. Case Rep Dermatol Med 2018; 2018: 2143089.
[http://dx.doi.org/10.1155/2018/2143089] [PMID: 30112220.]
[44]
Leung AKC, Lam JM, Leong KF. Childhood solitary cutaneous mastocytoma: Clinical manifestations, diagnosis, evaluation, and management. Curr Pediatr Rev 2019; 15(1): 42-6.
[http://dx.doi.org/10.2174/1573396315666181120163952] [PMID: 30465511]
[45]
Sharma A, Lambert PJ, Maghari A, Lambert WC. Arcuate, annular, and polycyclic inflammatory and infectious lesions. Clin Dermatol 2011; 29(2): 140-50.
[http://dx.doi.org/10.1016/j.clindermatol.2011.02.001] [PMID: 21396553]
[46]
Trayes KP, Savage K, Studdiford JS. Annular lesions: Diagnosis and treatment. Am Fam Physician 2018; 98(5): 283-91.
[PMID: 30216021]
[47]
Unwala R. Approach to the patient with annular skin lesions. In: Post TW, ed. UpToDate. Waltham, MA. (Accessed on May 30, 2020).
[48]
Wong HK. Novel biomarkers, dysregulated epigenetics, and therapy in cutaneous T-cell lymphoma. Discov Med 2013; 16(87): 71-8.
[PMID: 23998443]
[49]
Hon KL, Leung AKC, Leung TNH, Lee VWY. Complementary, alternative and integrative medicine for childhood atopic dermatitis. Recent Pat Inflamm Allergy Drug Discov 2017; 11(2): 114-24.
[http://dx.doi.org/10.2174/1872213X11666171128142333] [PMID: 29189188]
[50]
Schuster B, Ziehfreund S, Albrecht H, et al. Happiness in dermatology: A holistic evaluation of the mental burden of skin diseases. J Eur Acad Dermatol Venereol 2019; 34(6): 1331-9.
[http://dx.doi.org/10.1111/jdv.16146] [PMID: 31838769]
[51]
Mori T, Yamamoto T. Bullous pemphigoid developed on nummular eczema lesions. J Dermatol 2019; 46(11): e426-7.
[http://dx.doi.org/10.1111/1346-8138.14990] [PMID: 31282017]
[52]
Hon KL, Leung AK, Barankin B. Barrier repair therapy in atopic dermatitis: An overview. Am J Clin Dermatol 2013; 14(5): 389-99.
[http://dx.doi.org/10.1007/s40257-013-0033-9] [PMID: 23757122]
[53]
Hon KL, Leung AK. Use of ceramides and related products for childhood-onset eczema. Recent Pat Inflamm Allergy Drug Discov 2013; 7(1): 12-9.
[http://dx.doi.org/10.2174/187221313804004673] [PMID: 23083072]
[54]
Purnamawati S, Indrastuti N, Danarti R, Saefudin T. The role of moisturizers in addressing various kinds of dermatitis: A review. Clin Med Res 2017; 15(3-4): 75-87.
[http://dx.doi.org/10.3121/cmr.2017.1363] [PMID: 29229630]
[55]
Almawi WY, Melemedjian OK. Molecular mechanisms of glucocorticoid antiproliferative effects: Antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 2002; 71(1): 9-15.
[PMID: 11781376]
[56]
Alomar A, Berth-Jones J, Bos JD, et al. European Working Group on Atopic Dermatitis. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol 2004; 151(Suppl 70): 3-27.
[http://dx.doi.org/10.1111/j.1365-2133.2004.06269.x] [PMID: 15548171]
[57]
Leung AK, Hon KL. Atopic Dermatitis: A Review for the Primary Care Physician New York: Nova Science Publishers, Inc. 2012; pp. 1-113.
[58]
Hon KLE, Wong KY, Cheung LK, et al. Efficacy and problems associated with using a wet-wrap garment for children with severe atopic dermatitis. J Dermatolog Treat 2007; 18(5): 301-5.
[http://dx.doi.org/10.1080/09546630701567386] [PMID: 17852642]
[59]
Leung AK, Barber KA. Managing childhood atopic dermatitis. Adv Ther 2003; 20(3): 129-37.
[http://dx.doi.org/10.1007/BF02850199] [PMID: 12956254]
[60]
Baumer JH. Atopic eczema in children, NICE. Arch Dis Child Educ Pract Ed 2008; 93(3): 93-7.
[PMID: 18495900]
[61]
Ricci G, Dondi A, Patrizi A, Masi M. Systemic therapy of atopic dermatitis in children. Drugs 2009; 69(3): 297-306.
[http://dx.doi.org/10.2165/00003495-200969030-00005] [PMID: 19275273]
[62]
Langley RG, Eichenfield LF, Lucky AW, Boguniewicz M, Barbier N, Cherill R. Sustained efficacy and safety of pimecrolimus cream 1% when used long-term (up to 26 weeks) to treat children with atopic dermatitis. Pediatr Dermatol 2008; 25(3): 301-7.
[http://dx.doi.org/10.1111/j.1525-1470.2008.00671.x] [PMID: 18577032]
[63]
Drake L, Prendergast M, Maher R, et al. The impact of tacrolimus ointment on health-related quality of life of adult and pediatric patients with atopic dermatitis. J Am Acad Dermatol 2001; 44(1)(Suppl.): S65-72.
[http://dx.doi.org/10.1067/mjd.2001.109814] [PMID: 11145797]
[64]
Kondo Y, Nakajima Y, Komatsubara R, et al. Short-term efficacy of tacrolimus ointment and impact on quality of life. Pediatr Int 2009; 51(3): 385-9.
[http://dx.doi.org/10.1111/j.1442-200X.2008.02741.x] [PMID: 19400811]
[65]
Whalley D, Huels J, McKenna SP, Van Assche D. The benefit of pimecrolimus (Elidel, SDZ ASM 981) on parents’ quality of life in the treatment of pediatric atopic dermatitis. Pediatrics 2002; 110(6): 1133-6.
[http://dx.doi.org/10.1542/peds.110.6.1133] [PMID: 12456910]
[66]
Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 2001; 44(1)(Suppl.): S58-64.
[http://dx.doi.org/10.1067/mjd.2001.109812] [PMID: 11145796]
[67]
Draelos ZD, Stein Gold LF, Murrell DF, Hughes MH, Zane LT. Post hoc analyses of the effect of crisaborole topical ointment, 2% on atopic dermatitis: Associated pruritus from phase 1 and 2 clinical studies. J Drugs Dermatol 2016; 15(2): 172-6.
[PMID: 26885784]
[68]
Hon KL, Leung AKC, Leung TNH, Lee VWY. Investigational drugs for atopic dermatitis. Expert Opin Investig Drugs 2018; 27(8): 637-47.
[http://dx.doi.org/10.1080/13543784.2018.1494723] [PMID: 30058384]
[69]
Stein Gold LF, Eichenfield LF. Topical therapy for atopic dermatitis: New and investigational agents. Semin Cutan Med Surg 2017; 36(4S): S99-S102.
[http://dx.doi.org/10.12788/j.sder.2017.050] [PMID: 29659644]
[70]
Zane LT, Chanda S, Jarnagin K, Nelson DB, Spelman L, Gold LS. Crisaborole and its potential role in treating atopic dermatitis: Overview of early clinical studies. Immunotherapy 2016; 8(8): 853-66.
[http://dx.doi.org/10.2217/imt-2016-0023] [PMID: 27283509]
[71]
Choi S, Zhu GA, Lewis MA, et al. Dupilumab treatment of nummular dermatitis: A retrospective cohort study. J Am Acad Dermatol 2020; 82(5): 1252-5.
[http://dx.doi.org/10.1016/j.jaad.2019.12.054] [PMID: 31923445]
[72]
Patruno C, Stingeni L, Hansel K, et al. Effectiveness of dupilumab for the treatment of nummular eczema phenotype of atopic dermatitis in adults. Dermatol Ther (Heidelb) 2020; 33(3): e13290.
[http://dx.doi.org/10.1111/dth.13290] [PMID: 32125741.]
[73]
Roberts H, Orchard D. Methotrexate is a safe and effective treatment for paediatric discoid (nummular) eczema: A case series of 25 children. Australas J Dermatol 2010; 51(2): 128-30.
[http://dx.doi.org/10.1111/j.1440-0960.2010.00634.x] [PMID: 20546220]
[74]
Knöpfel N, Noguera-Morel L, Hernández-Martín A, Torrelo A. Methotrexate for severe nummular eczema in children: Efficacy and tolerability in a retrospective study of 28 patients. Pediatr Dermatol 2018; 35(5): 611-5.
[http://dx.doi.org/10.1111/pde.13568] [PMID: 29943852]
[75]
Leung AK, Wong BE, Chan PY, Cho HY. Pruritus in children. J R Soc Promot Health 1998; 118(5): 280-6.
[http://dx.doi.org/10.1177/146642409811800513] [PMID: 10076688]
[76]
Malekzad F, Arbabi M, Mohtasham N, et al. Efficacy of oral naltrexone on pruritus in atopic eczema: A double-blind, placebo-controlled study. J Eur Acad Dermatol Venereol 2009; 23(8): 948-50.
[http://dx.doi.org/10.1111/j.1468-3083.2009.03129.x] [PMID: 19453814]
[77]
Gunther B, Scherer D, Theisinger B, Theisinger S. Topical pharmaceutical composition based on semifluorinated alkanes. AU2017200622, 2017 & AU2018206812, 2018.
[78]
Dibas MI, Hsia EC, Donello JE, Gil DW. Pharmaceutical compositions comprising 7-(1H-imidazole-4-ylmethyl)-5,6,7,8-tetrahydro-quinoline for treating skin diseases and conditions. US20170182028, 2017.
[79]
Cutcliffe C, Eid JS, Bullard JH, Schicklberger MF, Cheng AT. Methods and compositions relating to microbial treatment and diagnosis of skin disorders. WO2016149687, 2016.
[80]
Wagner P. Compositions for the treatment of skin conditions. WO2019217203, US20190321416 & US20190343856, 2019.
[81]
Spakevicius D. Novel formulations and methods for treating dermatological disorders and diseases. US20180256477, 2018.
[82]
Zhang X, Schnipper EF, Perlman AJ, Larrick JW. Use of NK-1 receptor antagonist serlopitant in pruritus. US20170348282, 2017.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 14
ISSUE: 2
Year: 2020
Published on: 10 August, 2020
Page: [146 - 155]
Pages: 10
DOI: 10.2174/1872213X14666200810152246
Price: $65

Article Metrics

PDF: 311
HTML: 5